SearchDictionaryMobileLogin

Fc Receptors (Fc Receptor)

1150  relevant articles (34 outcomes, 102 trials/studies) found for this Bio-Agent

Description: Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules.

Also Known As:
Fc Receptor; Receptors, Fc; Receptor, Fc

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ravetch, Jeffrey V: 6 articles (02/2008 - 06/2002)
2. Takai, Toshiyuki: 5 articles (01/2007 - 02/2002)
3. Nimmerjahn, Falk: 3 articles (02/2008 - 03/2006)
4. Ra, Chisei: 3 articles (12/2005 - 06/2002)
5. Okumura, Ko: 3 articles (12/2005 - 06/2002)
6. Nakamura, Akira: 3 articles (02/2005 - 02/2002)
7. Saito, Takashi: 2 articles (02/2008 - 02/2003)
8. Czerwinski, Debra: 2 articles (02/2007 - 12/2004)
9. Weng, Wen-Kai: 2 articles (02/2007 - 12/2004)
10. Levy, Ronald: 2 articles (02/2007 - 12/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Infection
3. Systemic Lupus Erythematosus (Libman-Sacks Disease)
4. Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
08/01/1995 - "Expression, saturation, and endocytosis of IgA Fc receptors (Fc alpha R) were analyzed in blood phagocytic cells of patients with alcoholic liver cirrhosis (ALC). "
08/01/1995 - "Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. "
04/01/1985 - "Twenty-one patients with primary IgA nephropathy, 7 patients with Henoch-Schönlein nephritis and 4 patients with IgA nephropathy associated to alcoholic liver cirrhosis were tested for Fc-receptor phagocyte function by measuring the clearance of radiolabelled IgG-sensitized erythrocytes in vivo and the immune phagocytosis by monocytes in vitro. "
10/01/1991 - "Fc receptor-mediated clearance of immunoglobulin G-coated autologous erythrocytes was studied in patients with primary biliary cirrhosis (n = 14), alcoholic liver cirrhosis (n = 5) and healthy reference individuals (n = 14). "
01/01/1985 - "The number of C3b receptors detected on 100 monocytes was significantly lower in patients with primary biliary cirrhosis (23.0 +/- 12.0, mean +/- 1 SD) compared with normal controls (57.4 +/- 16.9) and other chronic liver disease (HBsAg negative chronic active hepatitis 62.0 +/- 17.0, alcoholic cirrhosis 50.9 +/- 4.0), while the number of Fc receptors detected on 100 monocytes was not significantly different in all the groups (primary biliary cirrhosis 72.8 +/- 28.6, chronic active hepatitis 74.7 +/- 14.0, alcoholic cirrhosis 58.0 +/- 13.5 and normal controls 69.6 +/- 19.9). "
Order ALL the reference details at left...
5. Autoimmune Diseases (Autoimmune Disease)

Related Drugs and Biologics

1. Immunoglobulin G (IgG)
2. Antigen-Antibody Complex (Immune Complex)
3. Antibodies
4. Immunoglobulin E (IgE)
5. tranilast (N 5')
6. Antigens
7. rituximab (Mabthera)
8. trastuzumab (Herceptin)
9. Suspensions
10. Interleukin-2 (IL2)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Immunotherapy
3. Ligation
4. Continuous Ambulatory Peritoneal Dialysis (CAPD)
5. Transplants (Transplant)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 20112 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>